FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:837-839 September 13, 2001 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The findings of Klein et al. (May 10 issue)¹ compel reexamination of fast-track cardioversion with the use of transesophageal echocardiography. Is it safe? The mortality rate was 2.5 times as high in the transesophageal-echocardiography group as in the conventional-treatment group (15 vs. 6 patients). The low probability that this difference was due to chance (P=0.06) should not be ignored. Is it beneficial? Sinus rhythm was not more likely at eight weeks, and functional capacity was not increased. Although fewer major hemorrhages occurred in the transesophageal-echocardiography group (5 vs. 9 patients), the clinical significance of this result is . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.